These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 856360)

  • 1. Detection of factor VIII inhibitors with the partial thromboplastin time.
    Lossing TS; Kasper CK; Feinstein DI
    Blood; 1977 May; 49(5):793-7. PubMed ID: 856360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and Measurement of Factor Inhibitors.
    Kershaw G
    Methods Mol Biol; 2017; 1646():295-304. PubMed ID: 28804837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro detection of mild inhibitors to factor VIII in hemophilia.
    Ewing NP; Kasper CK
    Am J Clin Pathol; 1982 Jun; 77(6):749-52. PubMed ID: 6807080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the agarose gel method to identify and quantitate factor VIII:C inhibitors.
    Cassidy PG; Triplett DA; LaDuca FM
    Am J Clin Pathol; 1985 Jun; 83(6):697-706. PubMed ID: 3923823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of activated partial thromboplastin time coagulation waveform analysis for identification of patients with acquired factor VIII inhibitors.
    McGinnis E; Wong SKW; Smith TW
    Int J Lab Hematol; 2020 Aug; 42(4):411-417. PubMed ID: 32297466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative measurement of FVIII inhibitors in hemophilia A patients using ELISA and the Bethesda assay.
    Kim SY; Kang SY; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):260-3. PubMed ID: 20603586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method.
    Torita S; Suehisa E; Kawasaki T; Toku M; Takeo E; Tomiyama Y; Nishida S; Hidaka Y
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):185-9. PubMed ID: 21245748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa: a preliminary study.
    Balôgôg PN; Tagny CT; Ndoumba A; Mbanya D
    Int J Lab Hematol; 2014 Oct; 36(5):566-70. PubMed ID: 25356499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis and laboratory findings in a patient with acquired hemophilia A].
    Xie BS; Wang WQ; Huang Y; Ye LL; Hu LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):206-8. PubMed ID: 19236780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
    Sultan Y; Brouet JC; Debre P
    N Engl J Med; 1974 Nov; 291(20):1087. PubMed ID: 4414451
    [No Abstract]   [Full Text] [Related]  

  • 13. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired hemophilia A in women postpartum: clinical manifestations, diagnosis, and treatment.
    Michiels JJ
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):82-6. PubMed ID: 10775027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors.
    McMillan CW; Shapiro SS; Whitehurst D; Hoyer LW; Rao AV; Lazerson J
    Blood; 1988 Feb; 71(2):344-8. PubMed ID: 3122859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The partial thromboplastin time in the CAP survey program.
    Koepke JA
    Am J Clin Pathol; 1975 Jun; 63(6 SUPPL):990-4. PubMed ID: 1146770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mild factor VIII Deficiency by thrombokinetics.
    Natelson EA; Shapiro D; Smith DF
    Am J Clin Pathol; 1975 Jul; 64(1):95-100. PubMed ID: 1155379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.